Journal of Food and Drug Analysis

(1)

參考文獻

[1] Chao PDL, Hsiu SL, Hou YC. Flavonoids in herbs: Biological fates and potential interactions with xenobiotics. Journal of Food and Drug Analysis. 2002; 10: 219-28.

[2] Bokkenheuser VD. Shackleton CH. Winter J. Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans.

Biochemical Journal. 1987; 248: 953-6.

[3] Miyake K. Arima H. Hirayama F. Yamamoto M. Horikawa T.

Sumiyoshi H. Noda S. Uekama K. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl- beta-cyclodextrin. Pharmaceutical Development & Technology. 2000;

5: 399-407.

[4] Torgils Fossen, Atle T. Pedersen and ψ yvind M. Andersen.

Flavonoids from red onion (ALLIUM CEPA). Phytochemistry. 1998;

47: 281-5.

[5] Koeppen BH, Van der Spuy JE, South African Journal of Agricultural Science. 1961; 4: 557.

[6] Brandewin BJ. The pigments in three cultivars of the common onion (Allium cepa). Journal of food Science. 1965; 30: 680-5.

[7] Hollman PC. de Vries JH. van Leeuwen SD. Mengelers MJ. Katan MB.

Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. American Journal of Clinical Nutrition. 1995;

62: 1276-82.

[8] 國家醫藥管理局中草藥情報中心站：植物藥有效成分手冊，人民衛

生出版社，北京，1986，pp. 185-6。

[9] Ortiz de Urbina AV, Martin ML, Fernandez B, San Roman L, Cubillo L. In vitro antispasmodic activity of peracetylated penstemonoside, aucubin and catalpol. Planta Medica. 1994; 60: 512-5.

[10] Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals.

New York: Pharmaceutical Products Press. 1994.

(2)

[11] Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. London: The Pharmaceutical Press.

1996.

[12] Hattori M, Shu ZY, Shimizu M, Hayashi T, Morita N, Kobashi K, Xu GJ, Namba T. Metabolism of paeoniflorin and related compounds by human intestinal bacteria. Chemical & Pharmaceutical Bulletin. 1985;

33: 3838-46.

[13] Shu YZ, Hattori M, Akao T, Kobashi K, Kagei K, Fukuyama K, Tsukihara T, Namba T. Metabolism of paeoniflorin and related compounds by human intestinal bacteria. II. Structures of 7S- and 7R-paeonimetabolines I and II formed by Bacteroides fragilis and Lactobacillus brevis. Chemical & Pharmaceutical Bulletin. 1987; 35:

3726-33.

[14] Hou YC, Hsiu SL, Huang TY, Yang CY, Tsai SY, Chao PDL. Effect of honey and sugars on the metabolism and disposition of naringin in rabbits. Planta Medica. 2001; 67: 538-41.

[15] George CF, et al. Presystemic drug elimination. Butter Worth Scientific:

London, 1982; pp 3-68, 198-205.

[16] 韓國柱。藥物在腸道的代謝及其對藥物作用的影響。藥學通報。

1985；120：1294-6。

[17] Kim DH, Jung EA, Sohng IS, Han JA, Kim TH, Han MJ. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Archives of Pharmacal Research. 1998; 21: 17-23.

[18] Roland IR. Factors affecting metabolic activity of the intestinal microflora. Drug Metabolism Reviews. 1988; 19: 243-61.

[19] 孫豔，李雪駝，殷素蘭。腸道內微生態環境對中草藥體內代謝的影響。中草藥。2001；32：375-7。

[20] Budavari S. The Merck Index, Merck & Co. Inc., 13^th ed., NJ, USA.

2001; pp. 123-4.

(3)

[21] Cheong H, Ryu SY, Oak MH, Cheon SH, Yoo GS, Kim KM. Studies of structure activity relationship of flavonoids for the anti-allergic actions.

Archives of Pharmacal Research. 1998; 21: 478-80.

[22] Basile A, Sorbo S, Giordano S, Ricciardi L, Ferrara S, Montesano D, Castaldo Cobianchi R, Vuotto ML, Ferrara L. Antibacterial and alleopathic activity of extract from Castanea sativa leaves. Fitoterapia.

2000; 71: 110-6.

[23] Romanova D, Vachalkova A, Cipak L, Ovesna Z, Rauko P. Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method. Neoplasma. 2001; 48: 104-7.

[24] Landolfi R, Mower RL, Steiner M. Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochemical & Pharmacology. 1984; 33: 1525-30.

[25] Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silveira R, Dajas F, Medina JH, Paladini AC. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Medica. 1995; 61: 213-6.

[26] Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB, Piantelli M. Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer. 2000; 87: 595-600.

[27] Kim TJ, Zhang YH, Kim Y, Lee Ck, Lee MK, Hong JT, Yun YP. Effect of apigenin on the serum-and platelet derived growth factor-BB-induced proliferation of rat aortic vascular smooth muscle cells. Planta Medica. 2002; 68: 605-9.

[28] Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

Endocrinology. 1998; 139: 4252-63.

2001; p. 580.

(4)

[30] Meng JC, Zhu QX, Tan RX. New antimicrobial mono- and sesquiterpenes from Soroseris hookeriana subsp. erysimoides. Planta Medica. 2000; 66: 541-4.

[31] Morel I, Lescoat G, Cogrel P, Sergent O, Pasdeloup N, Brissot P, Cillard P, Cillard J. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochemical Pharmacology. 1993; 45: 13-9.

[32] Sher E, Codignola A, Biancardi E, Cova D, Clementi F. Amine uptake inhibition by diosmin and diosmetin in human neuronal and neuroendocrine cell lines. Pharmacological Research. 1992; 26:

395-402.

[33] Bae EA, Han MJ, Kim DH. In vitro anti-Helicobacter pylori activity of some flavonoids and their metabolites. Planta Medica. 1999; 65:

442-3.

[34] Doostdar H, Burke MD, Mayer RT. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology.

2000; 144: 31-8.

2001; p. 1006.

[36] Vrijsen R, Everaert L, Boeye A. Antiviral activity of flavones and potentiation by ascorbate. Journal of General Virology. 1988; 69:

1749-51.

[37] Kimata M, Inagaki N, Nagai H. Effects of luteolin and other flavonoids on Ig E-meditated allergic reactions. Planta Medica. 2000;

66: 25-9.

[38] Kim JS, Kwon CS, Son KH. Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Bioscience, Biotechnology &

Biochemistry. 2000; 64: 2458-61.

[39] Elangovan V, Sekar N, Govindasamy S. Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Letters. 1994; 87:107-13.

(5)

[40] Ko WG, Kang TH, Lee SJ, Kim YC, Lee BH. Effects of luteolin on the inhibition of proliferation and induction of apoptosis in human myeloid leukaemia cells. Phytotherapy Research. 2002; 16: 295-8.

[41] Chowdhury AR, Sharma S, Mandal S, Goswami A, Mukhopadhyay S, Majumder HK. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I. Biochemical Journal. 2002; 366:

653-61.

[42] Larson, RA. The antioxidants of higher plants. Phytochemistry. 1988;

27: 969-78.

2001; p. 165.

[44] 蕭崇厚：中藥化學，上海科學技術出版社，上海，1985，p. 246。

[45] Nagai T, Yamada H, Otsuka Y. Inhibition of mouse liver sialidase by the root of Scutellaria baicalensis. Planta Medica. 1989; 55: 27-9.

[46] Nakahata N, Kutsuwa M, Kyo R, Kubo M, Hayashi K, Ohizumi Y.

Analysis of inhibitory effects of Scutellariae Radix and baicalein on prostaglandin E₂ production in rat C6 glioma cells. American Journal of Chinese Medicine. 1998; 26: 311-23.

[47] Yakizawa H, DelliPizzi AM, Nasjletti A. Prostaglandin I₂ contributes to the vasodepressor effect of baicalein in hypertensive rats.

Hypertension. 1998; 31: 866-71.

[48] Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, Kishimoto T. Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology. 2000; 55: 951-5.

[49] Motoo Y, Sawabu N. Antitumor effects of saikosaponins, baicalin and baicalein on human hepatoma cell lines. Cancer Letters. 1994; 86:

91-5.

[50] Matsuzaki Y, Kurokawa N, Terai S, Matsumura Y, Kobayashi N, Okita K. Cell death induced by baicalein in human hapatocellular carcinoma cell lines. Japanese Journal of Cancer Research. 1996; 87: 170-7.

(6)

[51] Chang WH, Chen CH, Lu FJ. Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Medica. 2002;

68: 128-32.

[52] So FV, Guthrie N, Chambers AF, Moussa M, Carroll KK. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutrition and Cancer.

l996; 26:167-81.

[53] So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen.

Cancer Letters.1997; 112: 127-33.

[54] Nyby MD, Sasaki M, Ideguchi Y, Wynne HE, Hori MT, Berger ME, Golub MS, Brickman AS, Tuck ML. Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic -induced intracellular calcium mobilization and platelet aggregation. The Journal of Pharmacology and Experimental Therapeutics. 1996; 278: 503-9.

[55] Kubo M, Matsuda H, Tani T, Arichi S, Kimura Y. Studies on Scutellariae Radix. XII. Anti-thrombic actions of various flavonoids from Scutellariae Radix. Chemical & Pharmaceutical Bulletin. 1985;

33: 2411-5.

[56] Kubo M, Matsuda H, Tanaka M, Kimura Y, Okuda H, Higashino M, Tani T, Namba K, Arichi S. Studies on Scutellariae Radix VI.

Anti-arthritic and anti-inflammatory actions of methanolic extract and flavonoid components from Scutellariae Radix. Chemical &

Pharmaceutical Bulletin. 1984; 32: 2724-29.

[57] Wakabayashi I. Inhibitory effects of baicalein and wogonin on lipopolysaccharide-induced nitric oxide production in macrophages.

Pharmacology & Toxicology. 1999; 84: 288-91.

[58] Kimuya Y, Kubo M, Tani T, Arichi S, Okuda H. Studies on Scutellariae Radix. IV. Effects on lipid peroxidation in rat liver. Chemical &

(7)

[59] Shieh DE, Liu LT, Lin CC. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Research. 2000;

20: 2861-65.

[60] Kimura Y, Kubo M, Tani T, Arichi S, Ohminami H, Okuda H. Studies on Scutellariae radix. III. Effects on lipid metabolism in serum, liver and fat cells of rats. Chemical & Pharmaceutical Bulletin. 1981; 29:

2308-12.

[61] Kimura Y, Kubo M, Kusaka K, Tani T, Higashino M, Arichi S, Okuda H. Studies on Scutellariae radix. V. Effects on ethanol-induced hyperlipemia and lipolysis in isolated fat cells. Chemical &

[62] 國家醫藥管理局中草藥情報中心站：植物藥有效成分手冊，人民衛生出版社，北京，1986，pp. 109-12。

2001; pp. 1490-1.

[64] Negre-Salvayre A, Affany A, Hariton C, Salvayre R. Additional antilipoperoxidant activities of alpha-tocopherol and ascorbic acid on membrane-like systems are potentiated by rutin. Pharmacology. 1991;

42: 262-72.

[65] Grinberg LN, Rachmilewitz EA, Newmark H. Protective effects of rutin against hemoglobin oxidation. Biochemical Pharmacology. 1994;

48: 643-9.

[66] Negre-Salvagyre A, Salvagyre R. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Radical Biology &

Medicine. 1992; 12: 101-6.

[67] Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F.

Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radical Biology & Medicine. 1995; 19: 481-6.

[68] Webster RP, Gawde MD, Bhattacharya RK. Protective effect of rutin, a flavonol glycoside, on the carcinogen-induced DNA damage and repair enzymes in rats. Cancer Letters. 1996; 109: 185-91.

(8)

[69] Deschner EE, Ruperto J, Wong G, Newmark HL. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia.

Carcinogenesis. 1991; 12: 1193-6.

[70] Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D, Newmark H, Steele VE, Kelloff GJ, Lipkin M. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis. 2000; 21:

1655-60.

[71] el-Gammal AA and Mansour RM. Antimicrobial activities of some flavonoid compounds. Zentralblatt fur Mikrobiologie. 1986; 141:

561-5.

[72] Lindahl M, Tagesson C. Flavonoids as phospholipase A2 inhibitors:

importance of their structure for selective inhibition of group II phospholipase A2. Inflammation. 1997; 21: 347-56.

[73] Chen YC, Shen SC, Lee WR, Hou WC, Yang LL, Lee TJ. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expression by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages.

Journal of Cellular Biochemistry. 2001; 82: 537-48.

[74] 江紀武、肖慶祥，植物藥有效成分手冊，人民衛生出版社，p. 902。

[75] Metodiewa D, Kochman A, Karolczak S. Evidence for antiradical and antioxidant properties of four biologically active N, N-diethylaminoethyl ethers of flavanone oximes: a comparison with natural polyphenolic flavonoid (rutin) action. Biochemistry &

Molecular Biology International. 1997; 41: 1067-75.

[76] La Casa C, Villegas I, Alarcon de la Lastra C, Motilva V, Martin Calero MJ. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. Journal of Ethnopharmacology. 2000; 71: 45-53.

[77] Gryglewski RJ, Korbut R, Robak J, Swies J. On the mechanism of antithrombotic action of flavonoids. Biochemical Pharmacology. 1987;

36: 317-22.

(9)

[78] Swies J, Robak J, Dabrowski L, Duniec Z, Michalska Z, Gryglewski RJ. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro. Polish Journal of Pharmacology & Pharmacy. 1984; 36: 455-63.

[79] da Silva RR, de Oliveira TT, Nagem TJ, Pinto AS, Albino LF, de Almeida MR, de Moraes GH, Pinto JG. Hypocholesterolemic effect of naringin and rutin flavonoids. Archivos Latinoamericanos de Nutricion.

2001; 51: 258-64.

2001; pp. 1438-9.

[81] de Whalley CV, Rankin SM, Hoult JR, Jessup W, Leake DS.

Flavonoids inhibit the oxidative modification of low-density lipoproteins by macrophages. Biochemical Pharmacology. 1990; 39:

1743-50.

[82] Kuhlman MK, Horsch E, Burkhardt G, Wagner M, Kohler H.

Reduction of cisplatin toxic ity in cultured renal tubular cells by the bioflavonoid quercetin. Archives of Toxicology. 1998; 72: 536-40.

[83] Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.

Nutrition & Cancer. 1997; 27: 31-40.

[84] Martin MJ, La-Casa C, Alarcon-de-la-Lastra C, Cabeza J, Villegas I, Motilva V. Anti-oxidant mechanisms involved in gastroprotective effects of quercetin. Zeitschrift fur Naturforschung – Section C – Biosciences. 1998; 53: 82-8.

[85] Alarcon de la Lastra C, Martin MJ, Motilva V. Antiulcer and gastroprotective effects of quercetin: a gross and histologic study.

Pharmacology. 1994; 48: 56-62.

[86] Kaul TN, Middleton E Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. Journal of Medical Virology. 1985; 15: 71-9.

(10)

[87] Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, Brown MB, Guo W, Rossi SJ, Benet LZ, Watkins PB. Role of intestinal P-glycoprotein (mdrl) in interpatient variation in the oral bioavailability of cyclosporine. Clinical Pharmacology &

Therapeutics. 1997; 62: 248-60.

[88] Critchfield JW, Welsh CJ, Phang JM, Yeh GC. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Biochemical Pharmacology. 1994; 48: 1437-45.

[89] Shapiro AB, Ling V. Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochemical Pharmacology.

1997; 53: 587-96.

[90] Galvez J, Crespo ME, Jimenez J, Suarez A, Zarzuelo A. Antidiarrhoeic activity of quercitrin in mice and rats. Journal of Pharmacy &

Pharmacology. 1993; 45: 157-9.

[91] Beretz A, Stierle A, Anton R, Cazenave JP. Role of cyclic AMP in th inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochemical & Pharmacology.

1982; 31: 3597-600.

[92] Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clinica Chimica Acta. 1995;

235: 207-19.

[93] Guengerich P, Kim DH. In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids. Carcinogenesis. 1990; 11: 2275-9.

[94] Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG.

Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. Journal of Pharmacology & Experimental Therapeutics. 1992; 261: 1195-9.

(11)

[95] Ho PC, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. Journal of Pharmacy & Pharmaceutical Sciences. 2001;

4:217-27.

[96] Calomme M, Pieters L, Vlietinck A, Vanden Berghe D. Inhibition of bacterial mutagenesis by Citrus flavonoids. Planta Medica. 1996; 62:

222-6.

[97] Divi RL, Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chemical Research in Toxicology. 1996; 9: 16-23.

[98] Huang Z, Fasco MJ, Kaminsky LS. Inhibition of estrone sulfatase in human liver microsomes by quercetin and other flavonoids. Journal of Steroid Biochemistry & Molecular Biology. 1997; 63: 9-15.

2001; pp. 1119-20.

[100] Galvez J, Coelho G, Crespo ME, Cruz T, Rodriguez-Cabezas ME, Concha A, Gonzalez M, Zarzuelo A. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Alimentary Pharmacology & Therapeutics. 2001; 15: 2027-39.

[101] Cheng CH. In vitro and in vivo inhibitory actions of morin on rat brain phosphatidylinositolphosphate kinase activity. Life Sciences. 1997; 61:

2035-47.

[102] Herrera MD, Zarzuelo A, Jimenez J, Marhuenda E, Duarte J. Effects of flavonoids on rat aortic smooth muscle contractility: structure-activity relationships. General Pharmacology. 1996; 27: 273-7.

[103] Wu TW, Fung KP, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by morin hydrate. Life Sciences. 1995; 57: 51-6.

2001; p. 944.

(12)

[105] Kataoka M, Hirata K, Kunikata T, Ushio S, Iwaki K, Ohashi K, Ikeda M, Kurimoto M. Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori - infected Mongolian gerbils. Journal of Gastroenterology. 2001; 36: 5-9.

[106] Mitrocotsa D, Mitaku S, Axarlis S, Harvala C, Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Medica. 2000; 66: 377-9.

[107] Goel RK, Pandey VB, Dwivedi SP, Rao YV. Antiinflammatory and antiulcer effects of kaempferol, a flavone, isolated from Rhamnus procumbens. Indian Journal of Experimental Biology. 1988, 26: 121-4.

[108] Revuelta MP, Cantabrana B, Hidalgo A. Mechanisms involved in kaempferol-induced relaxation in rat uterine smooth muscle. Life Sciences. 2000; 67: 251-9.

2001; p. 1151.

[110] Ng TB, Liu F, Wang ZT. Antioxidative activity of natural products from plants. Life Sciences. 2000; 66: 709-23.

[111] Jeon SM, Bok SH, Jang MK, Kim YH, Nam KT, Jeong TS, Park YB, Choi MS. Comparison of antioxidant effects of naringin and probucol in cholesterol-fed rabbits. Clinica Chimica Acta. 2002; 317:181-90.

[112] Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sciences. 2001; 69:2855-66.

[113] Martin MJ, Marhuenda E, Perez-Guerrero C, Franco JM. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats.

Pharmacology. 1994; 49: 144-150.

[114] Shin YW, Bok SH, Jeong TSBae KH, Jeoung NH, Choi MS, Lee SH, Park YB. Hypocholesterolemic effect of naringin associated with hepatic cholesterol regulating enzyme changes in rats. International Journal for Vitamin & Nutrition Research. 1999; 69: 341-7.

(13)

[115] Ramesh N, Viswanathan MB, Saraswathy A, Balakrishna K, Brindha P, Lakshmanaperumalsamy P. Phytochemical and antimicrobial studies on Drynaria quercifolia. Fitoterapia. 2001; 72: 934-6.

2001; p. 1151.

[117] Zhu BT, Taneja N, Loder DP, Balentine DA, Conney AH. Effects of tea polyphenols and flavonoids on liver microsomal glucuronidation of estradiol and estrone. Journal of Steroid Biochemistry & Molecular Biology. 1998; 64: 207-15.

[118] Kroyer G. The antioxidant activity of citrus fruit peels. Zeitschrift fur Ernahrungswissenschaft. 1986; 25: 63-9.

[119] Parmar NS. The gastric anti-ulcer activity of naringenin, a specific histidine decarboxylase inhibitor. International Journal of Tissue Reactions. 1983; 5: 415-20.

[120] Corvazier E, Maclouf J. Interference of some flavonoids and non-steroidal anti-inflammatory drugs with oxidative metabolism of arachidonic acid by human platelets and neutrophils. Biochimica et Biophysica Acta. 1985; 835: 315-21.

2001; pp. 833-4.

[122] Matsuda H, Yano M, Kubo M, Iinuma M, Oyama M, Mizuno M.

Pharmacological study on citrus fruits. II. Anti-allergic effect of fruit of Citrus unshiu MARKOVICH (2). On flavonoid components.

Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan.

1991; 111: 193-8.

[123] Labrid C. Pharmacologic properties of Daflon 500 mg. Angiology.

1994, 45: 524-30.

[124] Yang M, Tanaka T, Hirose Y, Deguchi T, Mori H, Kawada Y.

Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine- induced urinary-bladder carcinogenesis in male ICR mice. International Journal of Cancer.

1997; 73: 719-24.

(14)

[125] Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A, Sumida T, Fukutani K, Tanaka T, Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Research. 1997; 57:

246-52.

[126] Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H. Chemoprevention of azoxymethane- induced at colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis. 1997;

18: 957-65.

[127] Franke AA, Cooney RV, Custer LJ, Morden LJ, Tanaka Y. Inhibition of neoplastic transformation and bioavailability of dietary flavonoid agents. Advances in Experimental Medicine & Biology. 1998; 439:

237-48.

[128] Monforte MT, Trovato A, Kirjavainen S, Forestieri AM, Galati EM, Lo Curo RB. Biological effects of hesperidin, a Citrus flavonoid. (note II):

hypolipidemic activity on experimental hypercholesterolemia in rat.

Farmaco. 1995; 50: 595-9.

[129] Miyake Y, Yamamoto K, Tsujihara N, Osawa T. Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids. 1998; 33:

689-95.

[130] Santus R, Perdrix L, Haigle J, Morliere P, Maziere JC, Maziere C, Labrid C. Daflon as a cellular antioxidant and a membrane-stabilizing agent in human fibroblasts irradiated by ultraviolet A radiation.

Photodermatology, Photoimmunology & Photomedicine. 1991; 8:

200-5.

[131] Galati EM, Trovato A, Kirjavainen S, Forestieri AM, Rossitto A, Monforte MT. Biological effects of hesperidin, a Citrus flavonoid.

(Note III): antihypertensive and diuretic activity in rat. Farmaco. 1996;

51: 219-21.

2001; p. 833.

(15)

[133] Guthrie N, Carroll KK. Inhibition of mammary cancer by Citrus flavonoids. Advances in Experimental Medicine & Biology. 1998; 439:

227-36.

[134] Lee SH, Jeong TS, Park YB, Kwon YK, Choi MS, Bok SH.

Hypocholesterolemic effect of hesperetin mediated by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase and acyl coenzyme A: cholesterol acyltransferase in rats fed high-cholesterol diet.

Nutrition Research, 1999; 19: 1245-58.

[135] Wu TS. Constituents of Formosan folk medicine. IV. The constituents of the leaves of Phellodendron wilsonii Hayata et Kanehira. Journal of the Chinese Chemical Society. 1979; 26: 25-8.

[136] Kim DH, Jung EA, Sohng IS, Han JA, Kim TH, Han MJ. Intestinal bacterial metabolism of flavonoids and its relation to some biological activities. Archives of Pharmaceutical Research. 1998; 21: 17-23.

[137] 陳鴻儀博士論文。黃柏素-7-葡萄糖? 於大白鼠之藥物動力學及其對環孢靈與長葉毛地黃動力學之影響，中國醫藥學院藥物化學研究所。2001；pp. 48-9。

[139] 季宇彬主編：中藥有效成分藥理與應用，黑龍江科學技術出版社，

哈爾濱，1994，pp. 360-4。

[140] Fan LL, Sun LH, Li J, Yue XH, Yu HX, Wang SY. The protective effects of puerarin against myocardial reperfusion injury study on cardiac function (J). Chinese Medical Journal. 1992; 105: 11-7.

[141] 曾貴雲、周遠鵬：葛根的藥理研究，中華醫學雜誌，1974；54：pp.

265-70。

[142] Lu XR, Gao E, Xu LZ, Li HZ, Kang B, Chen WN, Chen SM, Chai XS.

Puerarin bate-adrenergic receptor blocking effect. Chinese Medical Journal. 1987; 100: 25-8.

(16)

[143] Yue HW, Hu XQ. Pharmacologic value of radix Puerariae and puerarin on cardiovascular system. Chung-Kuo Chung His i Chieh Ho Tsa Chih.

1996; 16: 382-4.

[144] 段重高、徐理納、李宏偉：葛根素對黃金鼠腦循環的影響，中華醫學雜誌，1991，71：516-517。

[145] Yin ZZ, Zeng GY. Pharmacology of puerarin (V). Effect of puerarin on platelet aggregation and release of 5-HT from platelets. Chung –Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao Acta Academiae Medicinae Sinicae.

1981; Suppl 1: 44-7.

[146] Shen ZF, Xie MZ. Hypoglycemic effect of the combined use of puerarin and asprarin in mice. Yao Xue Xue Bao. 1985; 20: 863-5.

[147] Xuan B, Zhou YH, Yang RL, Li N, Min ZD, Chiou GC. Improvement of ocular blood flow and retinal functions with puerarin analogs.

Journal of Ocular Pharmacology & Therapeutics. 1999; 15: 207-16.

2001; p. 492.

[149] Keung WM, Lazo O, Kunze L, Vallee BL. Potentiation of the bioavailability of daidzin by an extract of Radix puerariae.

Proceedings of the National Academy of Sciences of the United States of America. 1996; 93: 4284-8.

[150] Keung MW, Vallee BL. Daidzin and its antidipsotropic analogs inhibit serotonin and dopamine metabolism in isolated mitochondria.

Proceedings of the National Academy of Sciences of the United States of America. 1998; 95: 2198-203.

[151] Uesugi T, Toda T. Tsuji K, Ishida H. Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavonoids, daidzin, genistin, and glycitin. Biological &

2001; pp. 491-2.

(17)

[153] van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE.

Phytooestrogens and cardiovascular disease risk. Nutrition Metabolism

& Cardiovascular Diseases. 2000; 10: 154-67.

[154] Han R. Highlight on the studies of anticancer drugs derived from plants in China. Stem Cells. 1994; 12: 53-63.

[155] Jing Y, Nakaya K, Han R. Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Research. 1993; 13: 1049-54.

[156] Zhang R, Li Y, Wang W. Enhancement of immune function in mice fed high dose of soy daidzein. Nutrition & Cancer. 1997; 29: 24-8.

[157] Jha HC, von Recklinghausen G, Zilliken F. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids. Biochemical Pharmacology. 1985; 34: 1367-9.

[158] Arora A, Nair MG, Strasburg GM. Antioxid ant activities of isoflavones and their biological metabolites in a liposomal system. Archives of Biochemistry & Biophysics. 1998; 356: 133-41.

[159] 簿廷相：葛根的解痙作用，遼寧中醫雜誌，1981；7：p. 27。

2001; p. 780.

[161] Allred CD, Ju YH, Allred KF, Chang J, Helferich WG. Dietary genistin stimulates growth of estrogen-dependent breast tumors similar to that observed with genistein. Carcinogenesis. 2001; 22: 1667-73.

[162] Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutrition & Cancer.

1994; 21: 113-31.

[164] Sugishita E, Amagaya S, Ogihara Y. Studies on the combination of Glycyrrhizae Radix in Shakuyakukanzo-To. Journal of Pharmacobiodynamics. 1984; 7: 427-35.

(18)

[165] Yamahara J, Yamada T, Kimura H, Sawada T, Fujimura H.

Biologically active principles of crude drugs. II. Anti-allergic principles in “Shoseiryu-To” anti-inflammatory properties of paeoniflorin and its derivatives. Journal of Pharmacobiodynamics.

1982; 5: 921-9.

[166] Kimura M, Kimura I, Nojima H. Depolarizing neuromuscular blocking action induced by electropharmacological coupling in the combined effect of paeoniflorin and glycyrrhizin. The Japanese Journal of Pharmacology. 1985; 37: 395-9.

[167] Hsu FL, Lai CW, Cheng JT. Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora. Planta Medica. 1997; 63: 323-5.

[168] Cheng JT, Wang JC, Hsu FL. Paeoniflorin reverses guanethidine-induced hypotension via activation of central adenosine A1 receptors in Wistar rats. Clinic & Experimental Pharmacology and Physiology. 1999; 26: 815-6.

[169] Lai CW, Hsu FL, Cheng JT. Stimulatory effect of paeoniflorin on adenosine A-1 receptors to increase the translocation of protein kinase C (PKC) and glucose transporter (GLUT 4) in isolate rat white adipocytes. Life Sciences. 1998; 62: 1591-5.

[170] Ye J, Duan H, Yang X, Yan W, Zheng X. Anti-thrombosis effect of paeoniflorin: Evaluated in a photochemical reaction thrombosis model in vivo. Planta Medica. 2001; 67: 766-7.

2001; p. 802.

[172] Hirabayashi K, Iwata S, Matsumoto H, Mori T, Shibata S, Baba M, Ito M, Shigeta S, Nakashima H, Yamamoto N. Antiviral activities of glycyrrhizin and its modified compounds against human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 1 (HSV-1) in vitro. Chemical & Pharmaceutical Bulletin. 1991; 39:

112-5.

(19)

[173] Pliasunova OA, Egoricheva IN, Fediuk NV, Pokrovskii AG, Baltina LA, Murinov IuI, Tolstikov GA. The anti-HIV activity of beta-glycyrrhizic acid. Voprosy Virusologii. 1992; 37: 235-8.

[174] Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW.

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Research Letters. 2003; 361: 2045-6.

[175] Chung JG, Chang HL, Lin WC, Wang HH, Yeh CC, Hung CF, Li YC.

Inhibition of N-acetyltransferase activity and DNA-2-aminofluorene adducts by glycyrrhizic acid in human colon tumor cells. Food &

Chemical Toxicology. 2000; 38: 163-72.

[176] Okimasu E, Moromizato Y, Watanabe S, Sasaki J, Shiraishi N, Morimoto YM, Miyahara M, Utsumi K. Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug.

Acta Medica Okayama. 1983; 37: 385-91.

[177] Akamatsu H, Komura J, Asada Y, Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions including reactive oxygen species generation. Planta Medica.

1991; 57: 119-21.

[178] Zhang YH, Isobe K, Iwamoto T, Nakashima I. Bidirectional control by glycyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathway. Immunology Letters. 1992; 32: 147-52.

[179] Kimura M, Watanabe H, Abo T. Selective activation of extrathymic T cells in the liver by glycyrrhizin. Biotherapy. 1992; 5: 167-76.

[180] Ruszymah BH, Nabishah BM, Aminuddin S, Sarjit S, Khalid BA.

Effects of glycyrrhizic acid and steroid treatment on corticotropin releasing factor and beta-endorphin containing neurons of the hypothalamus of the rat. Malaysian Journal of Pathology. 1999; 21:

51-8.

[181] Sakamoto K, Wakabayashi K. Inhibitory effect of glycyrrhetinic acid on testosterone production in rat gonads. Endocrinologia Japonica . 1988; 35: 333-42.

(20)

[182] Okamoto T. The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice. European Journal of Pharmacology. 2000; 387: 229-32.

[183] Crance JM, Leveque F, Biziagos E, van Cuyck-Gandre H, Jouan A, Deloince R. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro. Antiviral Research. 1994; 23:

63-76.

[184] Akao T. Localization of enzyme involved in metabolism of glycyrrhizin in contents of rat gastrointestinal tract. Biological &

Pharmaceutical Bulletin.1997; 20: 122-6.

[185] 服部征雄，他：腸內細菌從による和漢藥成分の代謝，漢方研究，

1983；6：pp. 178-89。

[187] Zakirov UB, Abdullaev AKh. The hypolipidemic and antiatherosclerotic properties of the ammonium salt of glycyrrhetic acid and 18-dehydroglycyrrhetic acid. Eksperimentalnaia I Klinicheskaia Farmakologiia. 1996; 59: 53-5.

[188] Nishino H, Yoshioka K, Iwashima A, Takizawa H, Konishi S, Okamoto H, Okabe H, Shibata S, Fujiki H, Sugimura T. Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Japanese Journal of Cancer Research. 1986; 77: 33-8.

[189] Imanishi N, Kawai H, Hayashi Y, Yatsunami K, Ichikawa A. Effect of glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release from rat peritoneal mast cells. Biochemical Pharmacology. 1989; 38: 2521-6.

(21)

[190] Horigome H, Horigome A, Homma M, Hirano T, Oka K.

Glycyrrhetinic acid-induced apoptosis in thymocytes: impact of 11 beta-hydroxysteroid dehydrgenase inhibition. American Journal of Physiology. 1999; 277: E624-30.

[191] Kroes BH, Beukelman CJ, van den Berg AJ, Wolbink GJ, van Dijk H, Labadie RP. Inhibition of human complement by beta-glycyrrhetinic acid. Immunology. 1997; 90: 119-20.

[192] Shim SB, Kim NJ, Kim DH. Beta-glucuronidase inhibitory activity and hepatoprotective effect of 18 beta-glycyrrhetinic acid from the rhizomes of Glycyrrhiza uralensis. Planta Medica. 2000; 66: 40-3.

[193] 中國藥材學，啟業書局，pp. 387-393。

[194] Fuzellier MC, Mortier F, Girard T, Payen J. Study of antibiotic properties of some anthraquinones using chromatographic microplates.

Annales Pharmaceutiques Francaises. 1981; 39: 313-8.

[195] Cyong J, Matsumoto T, Arakawa K, Kiyohara H, Yamada H, Otsuka Y.

Anti-Bacteroides fragilis substance from rhubarb. Journal of Ethnopharmacology. 1987; 19: 279-83.

[196] Lu M, Chen QH, Biochemical study of Chinese rhubarb XXIX.

Inhibitory effects of anthraquinone derivatives on P338 leukaemia in mice. Journal of China Pharmaceutical University. 1989; 20: 155-7.

[197] Goel RK, Das Gupta G, Ram SN, Pandey VB. Antiulcerogenic and anti-inflammatory effects of emodin, isolated from Rhamnus triquerta wall. Indian Journal of Experimental Biology. 1991; 29: 230-2.

[198] Chang CH, Lin CC, Yang JJ, Namba T, Hattori M. Anti-inflammatory effects of emodin from ventilago leiocarpa. American Journal of Chinese Medicine. 1996; 24: 139-42.

2001; p. 56.

[200] Agarwal SK, Singh SS, Verma S, Kumar S. Antifungal activity of anthraquinone derivatives from Rheum emodi. Journal of Ethnopharmacology. 2000; 72: 43-6.

(22)

[201] Shi YQ, Fukai T, Sakagami H, Kuroda J, Miyaoka R, Tamura M, Yoshida N, Nomura T. Cytotoxic and DNA damage-inducing activities of low molecular weight phenols from rhubarb. Anticancer Research.

2001; 21: 2847-53.

[202] Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sciences. 2002; 71: 1879-92.

[203] Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G.

Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Research. 2000; 60: 2800-4.

[204] Saleem R, Faizi S, Siddiqui BS, Ahmed M, Hussain SA, Qazi A, Dar A, Ahmad SI, Qazi MH, Akhtar S, Hasnain SN. Hypotensive effect of chemical constituents from Aloe barbadensis. Planta Medica. 2001; 67:

757-60.

[205] Yagi T, Yamauchi K. Synergistic effects of anthraquinones on the purgative activity of rhein anthrone in mice. Journal of Pharmacy &

Pharmacology. 1999; 51: 93-5.

[206] Wang HH, Chung JG, Ho CC, Wu LT, Chang SH. Aloe-emodin effects on arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori. Planta Medica. 1998; 64: 176-8.

2001; p. 391.

[208] Choi JS, Lee HJ, Park KY, Ha JO, Kang SS. In vitro antimutagenic effects of anthraquinone aglycones and naphthopyrone glycosides from Cassia tora. Planta Medica. 1997; 63: 11-4.

[209] Koyama M, Takahashi K, Chou TC, Darzynkiewicz Z, Kapuscinski J, Kelly TR, Watanabe KA. Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2.

Derivatives of chrysophanol and emodin. Journal of Medicinal Chemistry. 1989; 32: 1594-9.

(23)

2001; pp. 629-30.

[211] Zhang C, Teng L, Shi Y, Jin J, Xue Y, Shang K, Gu J. Effect of emodin on proliferation and differentiation of 3T3-L1 preadipocyte and FAS activity. Chinese Medical Journal. 2002; 115: 1035-8.

[212] Matsuda H, Shimoda H, Morikawa T, Yoshikawa M. Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae):

structure-requirement of hydroxyanthraquinones for estrogenic activity.

Bioorganic & Medicinal Chemistry Letters. 2001; 11: 1839-42.

[213] Yim H, Lee YH, Lee CH, Lee SK. Emodin, an anthraquinone derivative isolated from the rhizomes of Rheum palmatum, selectively inhibits the activity of casein kinase II as a competitive inhibitor.

Planta Medica. 1999; 65: 9-13.

[214] Chung JG, Wang HH, Wu LT, Chang SS, Chang WC. Inhibitory actions of emodin on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Food & Chemical Toxicology. 1997; 35: 1001-7.

[215] Kuo YC, Sun CM, Ou JC, Tsai WJ. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sciences. 1997; 61: 2335-44.

[216] Ishii Y, Tanizawa H, Takino Y. Studies of aloe III. Mechanism of cathartic effect (2). Chemical & Pharmaceutical Bulletin. 1990; 38:

197-200.

[217] Lin CC, Chang CH, Yang JJ, Namba T, Hattori M. Hepatoprotective effects of emodin from Ventilago leiocarpa. Journal of Ethnopharmacology. 1996; 52: 107-11.

[218] Huang HC, Chang JH, Tung SF, Wu RT, Foegh ML, Chu SH.

Immunosuppressive effect of emodin, a free radical generator.

European Journal of Pharmacology. 1992; 211: 359-64.

[219] Huang HC, Lee CR, Chao PD, Chen CC, Chu SH. Vasorelaxant effect of emodin, an anthraquinone from a Chinese herb. European Journal of Pharmacology. 1991; 205: 289-94.

(24)

[220] Chen XY. Effects of emodin and other antibiotics on the antibiotics resistant plasmids of Staphylicoccus aureus. Journal of Nanjing College of Pharmacy. 1985; 16: 48-52.

2001; p. 1466.

[222] Chung JG, Tsou MF, Wang HH, Lo HH, Hsieh SE, Yen YS, Wu LT, Chang SH, Ho CC, Hung CF. Rhein affects arylamine N-acetyltransferase activity in Helicobacter pylori from peptic ulcer patients. Journal of Applied Toxicology. 1998; 18: 117-23.

[223] Martel-Pelletier J, Mineau F, Jolicoeur FC, Cloutier JM, Pelletier JP. In vitro effects of diacerhein and rhein on interleukin 1 and tumor necrosis factor-alpha systems in human osteoarthritic synovium and chondrocytes. Journal of Rheumatology. 1998; 25: 753-62.

2001; p. 1516.

[225] Lemli J. The mechanism of action of sennosides. Annales de Gastroenterologie et d Hepatologie. 1996; 32: 109-12.

[226] Hattori M, Namba T, AkaoT, Kobashi K. Metabolism of sennosides by human intestinal bacteria. Pharmacology. 1988; 36: 172-9.

[227] Chen HY, Wu TS, Wang JP, Kuo SH, Chao PDL. The fate of phellamurin in rats. The Chinese Pharmaceutical Journal. 2001; 53:

37-44.

[228] Kim DH, Yu KU, Bae EA, Han MJ. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity. Biological & Pharmaceutical Bulletin. 1998; 21: 628-30.

[229] Coldham NG, Darby C, Hows M, King LJ, Zhang AQ, Sauer MJ.

Comparative metabolism of genistin by human and rat gut microflora:

detection and identification of the end-products of metabolism.

Xenobiotica. 2002; 32:45-62.

[230] Hur HG, Lay JO Jr, Beger RD, Freeman JP, Rafii F. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin. Archives of Microbiology. 2000; 174:422-8.

(25)

[231] Winter J. Moore LH. Dowell VR Jr. Bokkenheuser VD. C-ring cleavage of flavonoids by human intestinal bacteria. Applied &

Environmental Microbiology. 1989; 55: 1203-8.

[232] Schneider H. Schwiertz A. Collins MD. Blaut M. Anaerobic transformation of quercetin -3-glucoside by bacteria from the human intestinal tract. Archives of Microbiology. 1999; 171: 81-91.

[233] Chen HY, Wu TS, Kuo SC, Chao PDL. The fate of Phellamurin in rats.

The Chinese Pharmaceutical Journal. 2001; 53: 37-44.

[234] Manach C. Morand C. Demigne C. Texier O. Regerat F. Remesy C.

Bioavailability of rutin and quercetin in rats. FEBS Letters. 1997; 409:

12-6.

[235] Erlund I. Kosonen T. Alfthan G. Maenpaa J. Perttunen K. Kenraali J.

Parantainen J. Aro A. Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. European Journal of Clinical Pharmacology. 2000; 56: 545-53.

[236] Yamasaki K, Kaneda M, Tanaka O. Carbon-13 NMR spectral assignments of paeoniflorin homologues with the aid of spin-lattice relaxation time. Tetrahedron Letters 1976; 44: 3965-8.

[237] Takeda S, Isono T, Wakui Y, Matsuzaki M, Sasaki H, Amagaya S, Maruno M. Absorption and excretion of paeoniflorin in rats. Journal of Pharmacy & Pharmacology. 1995; 47: 1036-40.

[238] Heikal OA, Akao T, Takeda S and Hattori M. Pharmacokinetic study of paeonimetabolin I, a major metabolite of paeoniflorin from Paeony Roots. Biological & Pharmaceutical Bulletin. 1997; 20: 517-21.

[239] 簡明藥材學，新醫藥出版社，許鴻源等著，p. 61-2。

[240] Seto T, Yasuda I, Hamano T, Takano I, Kiyono SI, Nishijima M, Akiyama K. Determination method of sennoside A, sennoside B, rhein and rhein 8-glucoside in kampo or crude drug preparations and the comparison of these components in processed Rhubarb. Natural Medicines. 1996; 50: 138-44.

(26)

[241] Okabe H, Matsuo K, Nishioka I. Studies on Rhubarb (Rhei Rhizoma).

II. Antrhraquinone glycosides. Chemical & Pharmaceutical Bulletin.

1973; 21: 1254-60.

[242] Dreessen M, Eyssen H, Lemli J. The metabolism of sennosides A and B by the intestinal mcroflora: in vitro and vivo studies on the rat and the mouse. Journal of Pharmacy and Pharmacology. 1981; 33:

679-81.

[243] Hattori M, Kim G, Motoike S, Kobashi K, Namba T. Metabolism of sennosides by intestinal flora. Chemical & Pharmaceutical Bulletin.

1982; 30: 1338-46.

[244] Kim DH, Park EK, Bae EA, Han MJ. Metabolism of rhaponticin and chrysophanol 8-o-beta-D-glucopyranoside from the rhizome of rheum undulatum by human intestinal bacteria and their anti-allergic action.

Biological & Pharmaceutical Bulletin. 2000; 23: 830-3.

[245] Ozaki Y, Noguchi M, Kamakura H, Harada M. Studies on concentration of glycyrrhizin in plasma and its absorption after oral administration of licorice extract and glycyrrhizin. Yakugaku Zasshi – Journal of the Pharmaceutical Society of Japan. 1990; 110: 77-81.

[246] Cantelli-Forti G, Maffei F, Hrelia P, Bugamelli F, Bernardi M, D’Intino P, Maranesi M, Raggi MA. Interaction of licorice on glycyrrhizin pharmacokinetics. Environmental Health Perspectives. 1994; 102:

65-68.